Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $40.42 USD
Change Today +0.95 / 2.41%
Volume 3.2M
GSK On Other Exchanges
Symbol
Exchange
OTC US
New York
Xetra
London
Mexico
Frankfurt
As of 3:00 PM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for glaxosmithkline plc-spon adr (GSK)

GlaxoSmithKline plc may have more financial risk than other companies in the Pharmaceuticals industry as it is one of the most highly leveraged with a Debt to Total Capital ratio of 79.19%. This ratio actually increased over the last year. However, an examination of near-term assets and liabilities shows that, even though there are not enough liquid assets to satisfy current obligations, Operating Profits are more than adequate to service the debt. Accounts Receivable are typical for the industry, with 59.67 days worth of sales outstanding. Last, GlaxoSmithKline plc is among the most efficient in its industry at managing inventories, with only 208.50 days of its Cost of Goods Sold tied up in inventory.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Restated
GBP
Dec 31
2012
Restated
GBP
Dec 31
2013
GBP
Dec 31
2014
GBP
4 Year
Trend
Assets    
Cash and Equivalents8,745.76,403.98,470.26,639.6
Short-Term Investments281.6124.0101.0105.6
Trading Asset Securities--35.2--107.1
TOTAL CASH AND SHORT TERM INVESTMENTS9,027.36,563.18,571.26,852.4
Accounts Receivable6,797.36,298.36,070.25,442.7
Notes Receivable62.861.256.642.9
Other Receivables1,282.61,385.21,956.11,323.9
TOTAL RECEIVABLES8,142.67,744.78,082.96,809.5
Inventory5,927.96,074.85,969.26,475.8
Prepaid Expenses518.9434.7443.9442.3
Other Current Assets1,128.0139.3238.81,885.7
TOTAL CURRENT ASSETS24,744.720,956.623,306.022,465.7
Gross Property Plant and Equipment27,833.427,951.328,070.728,903.3
Accumulated Depreciation-14,444.0-14,519.0-14,491.4-15,048.6
NET PROPERTY PLANT AND EQUIPMENT13,389.413,432.313,579.213,854.7
Goodwill5,745.86,671.86,436.05,699.8
Long-Term Investments1,890.32,173.42,335.62,225.4
Deferred Tax Assets, Long Term4,360.63,659.63,189.74,114.2
Other Intangibles11,941.515,552.114,208.312,734.3
Other Long-Term Assets803.51,043.81,360.71,125.0
TOTAL ASSETS62,875.863,489.664,415.662,219.2
    
LIABILITIES & EQUITY    
Accounts Payable3,930.54,080.54,192.24,270.3
Accrued Expenses4,255.05,992.26,261.66,596.8
Short-Term Borrowings166.83,100.92,745.81,478.5
Current Portion of Long-Term Debt/Capital Lease3,962.62,456.61,522.93,025.9
Current Portion of Capital Lease Obligations52.041.341.342.9
Current Income Taxes Payable2,514.72,103.02,222.41,446.4
Other Current Liabilities, Total8,086.03,163.73,733.13,436.1
Unearned Revenue, Current58.2248.0255.694.9
TOTAL CURRENT LIABILITIES22,973.921,144.820,933.620,348.9
Long-Term Debt18,584.222,380.023,575.424,158.5
Capital Leases93.475.081.187.2
Minority Interest1,216.81,434.11,247.41,030.1
Pension & Other Post-Retirement Benefits4,731.04,776.93,350.44,865.7
Deferred Tax Liability Non-Current1,258.11,536.71,060.7681.1
Other Non-Current Liabilities1,725.03,264.73,457.64,522.8
TOTAL LIABILITIES49,365.553,178.152,458.854,664.3
Common Stock2,122.92,064.72,044.82,049.4
Additional Paid in Capital2,560.63,094.83,971.84,222.8
Retained Earnings3,552.5-312.2500.5-2,964.7
Comprehensive Income and Other4,057.54,030.04,192.23,217.3
TOTAL COMMON EQUITY12,293.58,877.310,709.46,524.8
TOTAL EQUITY13,510.310,311.511,956.87,554.9
TOTAL LIABILITIES AND EQUITY62,875.863,489.664,415.662,219.2
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GSK:US $40.42 USD +0.95

GSK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AbbVie Inc $60.71 USD +0.205
Bristol-Myers Squibb Co $59.22 USD +1.02
Celgene Corp $118.12 USD +2.66
Eli Lilly & Co $81.03 USD +1.23
Medtronic PLC $70.98 USD +1.45
View Industry Companies
 

Industry Analysis

GSK

Industry Average

Valuation GSK Industry Range
Price/Earnings 6.6x
Price/Sales 2.7x
Price/Book 9.3x
Price/Cash Flow 6.6x
TEV/Sales 2.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLAXOSMITHKLINE PLC-SPON ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.